Trichloroethylene
CASRN 79-01-6 | DTXSID0021383
- IRIS Summary (PDF) (63 pp, 507.8 KB)
- Supporting Documents for Trichloroethylene
Applying Mode-Of-Action And Pharmacokinetic Considerations In The Contempary Cancer Risk Assessments: An Example With Trichloroethylene (Clewell And Andersen, 2004)
On this page:
Overview
Letter to the Editor - response to Clewell and Andersen (2004) [regarding TCE health risk assessment]
Citation
CALDWELL, J. C., M. V. EVANS, A. MARCUS, C. S. SCOTT, W. CHIU, M. S. OKINO, AND P. W. PREUSS. Applying Mode-Of-Action And Pharmacokinetic Considerations In The Contempary Cancer Risk Assessments: An Example With Trichloroethylene (Clewell And Andersen, 2004). CRITICAL REVIEWS IN TOXICOLOGY. CRC Press LLC, Boca Raton, FL, 36(3):291-294, (2006).
Download(s)
If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.
Critical Effect Systems
Tumor Sites
Chemical Structure for
Trichloroethylene
